ACR applauds FDA guidance requiring distinct names and suffixes for biosimilars
WASHINGTON, DC (Jan. 13, 2017) - The American College of Rheumatology (ACR) today applauded final guidance from the Food and Drug Administration recommending distinct suffixes...